Fluconazole resistant opportunistic oro-pharyngeal candida and non-candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria

African Health Sciences

Volumn 8, Issue 3, 2008, Pages 142-148

  Enwuru, C A ^a   Ogunledun, A ^b   Idika, N ^a   Enwuru, N V ^c   Ogbonna, F ^a   Aniedobe, M ^a   Adeiga, A ^a  

^a NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

^b OLABISI ONABANJO UNIVERSITY   (Nigeria)

^c LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

Author keywords

HIV AIDS and fluconazole resistance; Oropharyngeal candida (yeast like cells)

Indexed keywords

FLUCONAZOLE; ANTIFUNGAL AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGAR DIFFUSION; AGED; ALGORITHM; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG TREATMENT FAILURE; FEMALE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MORPHOTYPE; NIGERIA; OPPORTUNISTIC INFECTION; OROPHARYNX CANDIDIASIS; SPECIES DISTRIBUTION; ADOLESCENT; AIDS RELATED COMPLEX; ANTIFUNGAL RESISTANCE; CANDIDA; CANDIDIASIS; CLASSIFICATION; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PHARYNX DISEASE; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NIGERIA; PHARYNGEAL DISEASES; QUESTIONNAIRES; YOUNG ADULT;

EID: 65349182943     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Priscilla de Laet Sant'Ana, ; Milan, E. P. ; Martinez, R. et al. Multicenter Brazilian Study of Oral Candida species Isolated from AIDs Patients. Mem. Inst. Oswaldo Cruz, Rio de Janeiro, 2002; 97(2): 253-257.
2. Hodgson, T. A. ; Rachanis C. C. Oral fungal and bacterial infection in HIV-infected individuals: an overview in Africa. Pub. Med. Journal National Library of Medicine UK 2002; 8 Suppl. 2: 80-7.
3. Andrew, B. More common opportunistic infections; their symptoms, diagnosis, prophylaxis and treatment Positive (+ve) Magazine issue 2003; 42: 1-10 htt://wwwhoshat.co.uk/03/06/030606htm
4. Garber, G. An overview of fungal infections. Drugs 2001; 61 Suppl 1: 1-12.
5. + T-lymphocyte count. Bahrain Journal of Commun Dis 2002,. 34(3): 160-70.
6. Dunic, I; Vesic, S; Jevtovic, D.J. Oral Candidiasis and seborrheic Dermatitis in HIV - infected patients on highly active antiretroviral therapy. HIV Med. Jan 2004, 5 (1): 50-4.
7. White, T. C.; Hollemann, S.; Dy, F.; Mirels, L. F.; Stevens, D.A. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrobial Agents Chemother, 2002; 46: 1704-1713.
8. Jabra-Rizk, M. A.; Falker, W. A.; Meiller, T. F. Fungal Biofilms and Drug Resistance. Emerging Infections Diseases 2004; 10 no 1 www.cdc.gov/eid
9. Lewis, RE; Kepser, ME; Pfaller, M.A. Update on clinical antifungal susceptibility testing for Candida species. Pharmacotherapy May - June 1998; 18 (3): 509-15.
10. Maenza, J. R. Risk factors for Fluconazole Resistant andidiasis in HIV-infected patients 1996; 173-219 http:/www.thebody.com/jh/moore/mar96/ snapshol.html
11. Bailey, D. A.; Feldman, P.J.F.; Bovey, M.; Gow, N.A.R.; Brown A.J.P. The Candida albicans HYR I gene, which is activated in response to kyhal development, belongs to a gene family of yeast cell wall proteins. J. Bacteriol 1996, 178: 5353-5360.
12. Pfaller, M. A.; Messer, S. A.; Hollis, R. J; Jones, J. N. et al. Trends in Species distribution and Susceptibility to fluconazole among blood Stream Isolates of Candida species in the United States. Diagn. Microbiol. Infect. Dis. 1999; 33: 217-222.
13. Million, L. Fluconazole- resistant recurrent oral candidiasis in human immunodeficiency Virus positive patients: persistence of Candida albicans strains with the same genotype. Journal of Clinical Microbiology, 1994; 32 (4); 1115-1118.
14. Espinel-lgroff, A. Clinical utility of invitro antifungal susceptibility testing Rev; Esp - Quimioter. June 2002, 13 (2): 161-6.
15. John-Heritage, University of Leeds Laboratory and Scientific Medicine course and the MICR 3290 Medical Microbiology Module 1996; 1-13 htt:/www.leeds.ac.uk/mbiology/ug/med/mycol.html
16. Rejane, P. N.; Maria, A. C. ;Guilherme, M. C. ;Ohane, M.C.M. Yeasts isolated from clinical samples of AIDs patients. Braz Journal of Microbiology 2002, 33(4) Sao Paulo. Print ISSN 1517-8382.
17. Rohde, B ; Hartmann, G. ; Haude, D. ; Kessieler, H. G. ; and Langen, M.L. Introducing Mycology by examples. Presented by Schering Aktiengesellschaft. Hamburg, 1980; 35-98.
18. nd. ed. ButterWorth - Heinemann 1984: 389-390.
19. th ed. ASM press. Washington D.C. 1995; 728.
20. Calderone, R.A. (editor) Candida and Candidiasis ASM press. American Society for Microbiology 1752 N. Street. N.W. Washington D.C. 2002, 3, 451.
21. nd·ed. 2002; 22(15).
22. Neil M. Ampel, M. D. Emerging Disease Issues and Fungal pathogens Associated with HIV infection. Emerging infectious Diseases 1996; 2(2) 1-11 http:www.cdc.gov/ncidiod/eid/vol.2No.2/ampel.htm
23. Reichart , P. A.; Khongkh- un-thian, P ; Bendick, C. Oral Manifestation in HIV-infected individuals from Thailand and Cambodia. Med. Microbiol. Immunol (berl), Aug. 2003; 192 (3): 157-60.
24. Lamagni, T.B.; Evans , B.G.; Shigematsu, M; Johnson, F.M. Emerging trends in the epidemiology of invasive mycoses in England and Wales. Epidemiol-Infec 2001; 126(3): 397-414.
25. Dolan, C. T. A practical approach to identification of yeastlike organisms. Amer. Journal of Clin. Pathol. 1971, 55: 580-590.
26. Huppert, M.; Harper, G. ;Sun, S. H. Rapid method for identification of yeasts. Journal of Clinical Microbiol. 1975; 2: 21-34.
27. Taschdjian, C. L.; Burchall, J. J.; Kozina, P. J. Rapid identification of Candida albicans by filamentation of serum and serum substitutes. Amer. Journal of Dis. Childh ,1960: 212-215.
28. Colman, D.C; Rinaldi, M.G.; Haynes, K.A. et al. Importance of Candida species other than Candida albicans as opportunity pathogens. Med Mycol 1998,36 (suppl.1): 156-165.
29. Tierno, P. M.; Milstoc, M (1977). Germ tube positive Candida tropicalis. Amer. Journal of Clin. Pathol, 1977; 68: 294-295.
30. Sangeorzan, J. A.; Bradley, S. F.; He, X,; Zarians, L. T. Epidemiology of oral candidiasis in HIV-infected patients; Colonization, infection, treatment and emergence of fluconazole resistance. American Journal of Med. 1994; 97: 339-346.
31. Gabriel Torres, M.D. An 'ounce' of prevention update on Prophylaxis for Fungal Infection: Gay Men's Health Crisis Treatment Issues.1991; 5(7) http://www.aegis.com/gmhc/1991/GM050702.html.
32. Lynch, M.E, ; Sobel, J. Comparative in-vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. Journal of Medical Vet nary Mycology 1994; 32 (4): 267-74
33. Carrillo-Mounoz, A. J.; Quindos, G; Tur-C; et al Invitro antifungal activity of liposomal amphotericin B, amphotericin B, Lipid complex amphotericin B, deoxycholate Fluconzole and itraconazole. Journal of Antimicrob- Chemotherapy 1990, 44 (3): 397-401.
34. Lachkel, S.; Srikantha, T.; Tsai, L.; Danicls, K.; Soll, D. R. Phenotypic switching in Candida glabrata involves phase specific regulation of the metallotheionein gene MT-II and the newly discovered homolysin gene HLP. Infect Immun. 2000; 68:884-895.
35. Vargas, K.; Messer, A.; Pfaller, M. et al, Elevated Phenotypic switching and drug resistance of Candida albicans from immunodeficiency virus positive individuals prior to first thrush episode. J. Chin. Microbiol. 2000; 38: 3595-3607